Moviprep

Ascorbic Acid, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It prepares the bowel for colonoscopy and sigmoidoscopy in adult patients. GNH USA supplies Moviprep as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moviprep is an osmotic laxative used for bowel cleansing before endoscopic procedures. - Colonoscopy: provides rapid bowel evacuation to allow clear visualization of the colon. - Sigmoidoscopy: cleanses the rectum and distal colon for accurate assessment. - Pre‑procedure bowel preparation: ensures adequate cleansing for accurate diagnostic evaluation.

Moviprep may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Abdominal discomfort: cramping or pain in the stomach area. - Bloating: sensation of fullness or swelling in the abdomen. - Vomiting: expulsion of stomach contents. - Headache: mild to moderate pain in the head. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body water requiring medical attention. - Electrolyte disturbances: significant changes in sodium, potassium or other electrolytes. - Acute renal impairment: sudden decline in kidney function. - Allergic reaction: rash, itching, swelling or difficulty breathing. - Colonic perforation: rare but serious tear in the bowel wall.

Before using Moviprep, consider the following safety measures. - Renal function assessment: evaluate kidney health to avoid worsening impairment. - Electrolyte monitoring: check baseline electrolyte levels, especially potassium and sodium. - Adequate hydration: ensure the patient drinks sufficient clear fluids as instructed. - Contraindication in obstruction: do not use in patients with known or suspected bowel obstruction. - Avoid in severe dehydration: postpone preparation until fluid balance is restored. - Store at ambient temperature: keep below 25°C, in the original pack, protected from moisture.

Moviprep can interact with other medicines that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: increase risk of severe electrolyte loss. - ACE inhibitors or ARBs: may exacerbate renal dysfunction and electrolyte abnormalities. - NSAIDs: can compound risk of kidney injury.

Moderate Interactions (Monitor Closely): - Other laxatives: may cause excessive bowel evacuation and dehydration. - Oral rehydration solutions: could alter intended fluid balance. - Corticosteroids: may increase susceptibility to electrolyte disturbances.